2476-213X

Journal of Clinical Infectious Diseases & Practice
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Accomplice of Kaposin Sarcoma-Associated Herpesvirus Infection: Human Immunodeficiency Virus-Associated Exosomes: Commentary

Abstract

Kaposi sarcoma herpesvirus (KSHV; also known as Human Herpes Virus 8 (HHV8)) is a causal agent for
Kaposi’s Sarcoma (KS), a leading cause of mortality and morbidity in people living with HIV/AIDS. In most of
sub-Saharan Africa, the seroprevalence of KSHV infection reaches over 50%. In the United States and Europe, the
prevalence of KSHV is less than 10% in the general population. Although KSHV infection is a key factor for KS to
develop, in most cases infection with KSHV alone does not lead to KS. Globally, KS incidence is around 1 in 100,000 in
the general population compared to 1 in 20 in HIV-infected individuals. That means HIV infection is the most important
cofactor of the KSHV infection. Despite advances in our understanding of virology and pathogenesis of KSHV in recent
years, but how HIV infection strengthens does the infection and transmission of KSHV are still not well understood.

Keywords

Top